NOVEL EPSTEIN BARR VIRUS IMMUNOTHERAPIES
    1.
    发明申请

    公开(公告)号:WO2023034828A1

    公开(公告)日:2023-03-09

    申请号:PCT/US2022/075703

    申请日:2022-08-30

    摘要: The present invention generally relates to immunogenic compositions (e.g., vaccines and immunotherapies) that induce an immune response against Epstein Barr Virus (EBV)-associated antigens. The present invention also relates to methods of use thereof for the treatment and prevention of EBV infection, EBV-associated cancer, or a combination thereof. In various embodiments, the EBV antigen comprises BamHI-A rightward frame 1 (BARF1).